English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Feb 8, 2026
CDMOs look to FDA's PreCheck program for support at new US production sites
Patient Daily
| Feb 8, 2026
Penn Medicine earns national recognition for top clinical research achievements
Patient Daily
| Feb 8, 2026
ACAAI offers guidance for an allergy-safe Valentine’s Day
Patient Daily
| Feb 8, 2026
HonorHealth Research Institute administers new investigational stroke drug as part of national trial
Patient Daily
| Feb 8, 2026
Study links long-term air pollution exposure with higher ALS risk
Patient Daily
| Feb 8, 2026
Global Virus Network urges action amid rising measles cases worldwide
Patient Daily
| Feb 8, 2026
Blocking brain immune cells prevents early-life memory loss in mice
Patient Daily
| Feb 8, 2026
Bio-detection dogs identify scent signature of aggressive canine cancer
Trending
+
Regulatory
Patient Daily
| Apr 28, 2026
Archo Advocacy CEO Toresco on PBMs: 'PBMs profit from keeping prices high. Patients pay the spread'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2026
Washington Post Opinion Editor on 340B drug discounts: 'The program has become a profit-making venture for big businesses'
+
Regulatory
Patient Daily
| Apr 29, 2026
USC Schaeffer Center's Sood on PBMs: 'If PBMs want to claim they save employers and patients billions, they should be willing to prove it'
+
Regulatory
Patient Daily
| Apr 24, 2026
Steve Forbes on 340B program: Hospitals use it ‘to divert taxpayer-subsidized benefits for patients to unrelated interests’
« First
«
…
77
78
79
80
81
82
83
…
»
Last »